Whipplewood Advisors’s Qiagen QGEN Stock Holding History

Whipplewood Advisors’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$743	Hold	19	–	–	﹤0.01%	582
2026 Q1	$761	Buy	+19	New	+$899	﹤0.01%	938
2025 Q3	–	Sell	-30	Closed	-$1.44K	–	957
2025 Q2	$1.44K	Buy	30 +23	+329%	+$1K	﹤0.01%	947
2025 Q1	$1.21K	Sell	7 -24	-77%	-$1.01K	﹤0.01%	993
2024 Q4	$1.43K	Buy	+31	New	+$1.39K	﹤0.01%	942

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Whipplewood Advisors's QGEN Position: Q2 2026 in Review

Whipplewood Advisors held its Qiagen (QGEN) position steady in Q2 2026 at 19 shares worth $743. The position accounts for ﹤0.01% of the portfolio, ranked #582.

Whipplewood Advisors first reported a position in QGEN in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.44K in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

Whipplewood Advisors held 19 shares of Qiagen worth $743 as of Q2 2026.
Whipplewood Advisors left its Qiagen share count unchanged in Q2 2026.
Qiagen made up ﹤0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #582 holding.
Whipplewood Advisors first reported a position in Qiagen in Q4 2024 and has held it in 5 quarters since.
Whipplewood Advisors's Qiagen position peaked at $1.44K in Q2 2025.
336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.